Tag: Drug innovation

Over 60% of the drugs on the World Health Organization's essential medicines list are classified as 'me-too' drugs, highlighting their widespread prevalence in healthcare. The question of whether these follow-on medications are justified, however, continues to be a contentious topic in the fields of pharmacology and pharmaceutical ethics.

Asthma affects approximately 25 million Americans, with many still experiencing breakthrough symptoms despite daily maintenance therapy. The newest inhaler for asthma to significantly change rescue treatment is AIRSUPRA, a dual-action option approved for adults that addresses both symptoms and inflammation.